Creative Financial Designs’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.2K Hold
2,811
﹤0.01% 975
2026
Q1
$45.7K Hold
2,811
﹤0.01% 925
2025
Q4
$47.2K Hold
2,811
﹤0.01% 886
2025
Q3
$43.6K Hold
2,811
﹤0.01% 897
2025
Q2
$36K Hold
2,811
﹤0.01% 974
2025
Q1
$35.7K Hold
2,811
﹤0.01% 939
2024
Q4
$36.9K Hold
2,811
﹤0.01% 892
2024
Q3
$42.4K Hold
2,811
﹤0.01% 825
2024
Q2
$39.8K Hold
2,811
﹤0.01% 805
2024
Q1
$38.3K Hold
2,811
﹤0.01% 795
2023
Q4
$37.8K Buy
2,811
+611
+28% +$7.52K ﹤0.01% 747
2023
Q3
$27.4K Hold
2,200
﹤0.01% 781
2023
Q2
$29.8K Hold
2,200
﹤0.01% 762
2023
Q1
$30.6K Buy
+2,200
New +$31.4K ﹤0.01% 702

Other funds holding HQL

Creative Financial Designs's HQL Position: Q2 2026 in Review

Creative Financial Designs held its abrdn Life Sciences Investors (HQL) position steady in Q2 2026 at 2,811 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Creative Financial Designs first reported a position in HQL in Q1 2023 and has held it in 14 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Creative Financial Designs held 2,811 shares of abrdn Life Sciences Investors worth $56.2K as of Q2 2026.
  • Creative Financial Designs left its abrdn Life Sciences Investors share count unchanged in Q2 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #975 holding.
  • Creative Financial Designs first reported a position in abrdn Life Sciences Investors in Q1 2023 and has held it in 14 quarters since.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.